Science Explorer Back to mapMap
Discussion
Researcher · Yokohama City University · Japan

Kentaro Muraoka

Kentaro Muraoka publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, on topics such as Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments and Renal and related cancers.

ORCID 0000-0001-6055-1857 OpenAlex
World rank
#5,224,197
of 7,710,434 ranked researchers
Rank in Japan
#170,123
of 383,136
Works
71
Citations
381
Citations per work
5.4
h-index
13
i10-index 13Top 38% in Pulmonary and Respiratory Medicine
Kentaro Muraoka

What does Kentaro Muraoka research?

Kentaro Muraoka's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 47 works · 65.7% of their workMedicine: 47 works · 65.7% of their workPulmonary and Respiratory Medicine: 19 works · 27.0% of their workSurgery: 17 works · 24.0% of their workOncology: 5 works · 6.4% of their workEpidemiology: 3 works · 4.9% of their workObstetrics and Gynecology: 2 works · 3.4% of their workEverything else: 18 works · 25.5% of their workLife Sciences: 6 works · 8.8% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 8.8% of their workMolecular Biology: 6 works · 8.8% of their workTHEIR WORKKentaro Muraoka71works
Life Sciences9%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4765.7%
  2. Everything else1825.5%
    1. Biochemistry, Genetics and Molecular Biology68.8%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Surgery24% of their works
  3. 3Molecular Biology9% of their works
  4. 4Oncology6% of their works
  5. 5Epidemiology5% of their works
  6. 6Obstetrics and Gynecology3% of their works

Research topics

Which keywords describe Kentaro Muraoka's research?

The keywords of their largest research topics: Immunotherapy, Molecular Characterization, Metastatic, Renal Cell Carcinoma, Bladder Cancer, Urothelial Carcinoma, Kidney Organoids and Nephrogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immunotherapy532 topics
  2. Molecular Characterization532 topics
  3. Metastatic341 topic
  4. Renal Cell Carcinoma341 topic
  5. Bladder Cancer191 topic
  6. Urothelial Carcinoma191 topic
  7. Kidney Organoids141 topic
  8. Nephrogenesis141 topic
  9. Primary Urethral Carcinoma121 topic
  10. Urachal Carcinoma121 topic
  11. Fibromuscular Dysplasia61 topic
  12. Obstetric Fistula61 topic
  13. Renal Artery Stenosis61 topic
  14. Vesicovaginal Fistula61 topic
  15. Epidemiology51 topic
  16. Immune Checkpoint Blockade51 topic
  17. PD-1 and PD-L151 topic
  18. Urinary Tract Infections51 topic

Where does Kentaro Muraoka work?

Kentaro Muraoka's main affiliation in the publication record is Yokohama City University, Japan.

How many publications and citations does Kentaro Muraoka have?

OpenAlex counts 71 works and 381 citations for Kentaro Muraoka, an h-index of 13, ranking #5,224,197 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kentaro Muraoka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.